XOVOLTIB 40MG DESCRIPTION: This is a Phase 2 trial examine the performance of a targeted cancer drug known as Xovoltib 40mg. Xovoltib 40mg tablet prohibits the EGFR protein, which is accepting to be included in driving the growth of chordoma tumors.This study is plan specifically for chordoma patients 18 years or older with recurrent or metastatic tumors. Xovoltib 40mg which is used as prescription drugs under the guidance of oncologist physician. INDICATION: Xovoltib 40mg tablet is used for the first-line treatment for patients with metastatic non-small cell lung cancer(NSCLC) MECHANISM OF ACTION: Afatinib ( Xovoltib 40mg tablet ) mechanism by preventing the activity of a group of proteins knowns as epidermal growth factor receptors (EGFR). Epidermal growth factor receptor is a protein which is included in the growth and spread of cancer cells; Afatinib( Xovoltib 40mg ) works by inhibiting the action of this protein. Afatinib( Xovoltib 40mg ta...